On December 22, 2025, Sensei Biotherapeutics, Inc. entered into Retention Agreements for its executives Christopher Gerry and Josiah Craver, setting their annual salaries at $425,000 and $400,000, respectively, effective November 14, 2025. They are also eligible for annual bonuses, with retention bonuses tied to their employment status until February 13, 2026.